Sandusky ZM - Search Results

1

Stereoselective Synthesis and Evaluation of C6″-Substituted 5a-Carbasugar Analogues of SL0101 as Inhibitors of RSK1/2.

Li M, Li Y, Ludwik KA, Sandusky ZM, Lannigan DA, O'Doherty GA. Li M, et al. Among authors: sandusky zm. Org Lett. 2017 May 5;19(9):2410-2413. doi: 10.1021/acs.orglett.7b00945. Epub 2017 Apr 25. Org Lett. 2017. PMID: 28441024

2

De novo synthesis and biological evaluation of C6″-substituted C4″-amide analogues of SL0101.

Mrozowski RM, Sandusky ZM, Vemula R, Wu B, Zhang Q, Lannigan DA, O'Doherty GA. Mrozowski RM, et al. Among authors: sandusky zm. Org Lett. 2014 Nov 21;16(22):5996-9. doi: 10.1021/ol503012k. Epub 2014 Nov 5. Org Lett. 2014. PMID: 25372628 Free PMC article.

3

Synthesis and Structure-Activity Relationship Study of 5a-Carbasugar Analogues of SL0101.

Li M, Li Y, Mrozowski RM, Sandusky ZM, Shan M, Song X, Wu B, Zhang Q, Lannigan DA, O'Doherty GA. Li M, et al. Among authors: sandusky zm. ACS Med Chem Lett. 2014 Nov 26;6(1):95-9. doi: 10.1021/ml5004525. eCollection 2015 Jan 8. ACS Med Chem Lett. 2014. PMID: 25589938 Free PMC article.

4

Regioselective Synthesis of a C-4'' Carbamate,C-6'' n-Pr Substituted Cyclitol Analogue of SL0101.

Li Y, Sandusky ZM, Vemula R, Zhang Q, Wu B, Fukuda S, Li M, Lannigan DA, O'Doherty GA. Li Y, et al. Among authors: sandusky zm. Org Lett. 2020 Feb 21;22(4):1448-1452. doi: 10.1021/acs.orglett.0c00042. Epub 2020 Feb 3. Org Lett. 2020. PMID: 32009414 Free PMC article.

5

Development of a RSK Inhibitor as a Novel Therapy for Triple-Negative Breast Cancer.

Ludwik KA, Campbell JP, Li M, Li Y, Sandusky ZM, Pasic L, Sowder ME, Brenin DR, Pietenpol JA, O'Doherty GA, Lannigan DA. Ludwik KA, et al. Among authors: sandusky zm. Mol Cancer Ther. 2016 Nov;15(11):2598-2608. doi: 10.1158/1535-7163.MCT-16-0106. Epub 2016 Aug 15. Mol Cancer Ther. 2016. PMID: 27528706 Free PMC article.

6

RSK2 Maintains Adult Estrogen Homeostasis by Inhibiting ERK1/2-Mediated Degradation of Estrogen Receptor Alpha.

Ludwik KA, Sandusky ZM, Stauffer KM, Li Y, Boyd KL, O'Doherty GA, Stricker TP, Lannigan DA. Ludwik KA, et al. Among authors: sandusky zm. Cell Rep. 2020 Jul 21;32(3):107931. doi: 10.1016/j.celrep.2020.107931. Cell Rep. 2020. PMID: 32697984 Free PMC article.

7

FACS protocol for direct comparison of cell populations isolated from mice.

Ludwik KA, Sandusky ZM, Wright EB, Lannigan DA. Ludwik KA, et al. Among authors: sandusky zm. STAR Protoc. 2021 Jan 13;2(1):100270. doi: 10.1016/j.xpro.2020.100270. eCollection 2021 Mar 19. STAR Protoc. 2021. PMID: 33490986 Free PMC article.

8

The Clinical Utility of ESR1 Mutations in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer.

Grinshpun A, Sandusky ZM, Jeselsohn R. Grinshpun A, et al. Among authors: sandusky zm. Hematol Oncol Clin North Am. 2023 Feb;37(1):169-181. doi: 10.1016/j.hoc.2022.08.016. Hematol Oncol Clin North Am. 2023. PMID: 36435608 Review.

9

ESR1 activating mutations: From structure to clinical application.

Grinshpun A, Chen V, Sandusky ZM, Fanning SW, Jeselsohn R. Grinshpun A, et al. Among authors: sandusky zm. Biochim Biophys Acta Rev Cancer. 2023 Jan;1878(1):188830. doi: 10.1016/j.bbcan.2022.188830. Epub 2022 Nov 4. Biochim Biophys Acta Rev Cancer. 2023. PMID: 36336145 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page